Cargando…
P052. Patient's subjective judgement on the ease of use, speed of onset of action, efficacy and tolerability of Diclofenac sodium HPβCD (25 mg/mL) solution for subcutaneous injection vs Diclofenac potassium 50 mg for oral solution for the acute treatment of migraine
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Milan
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715154/ https://www.ncbi.nlm.nih.gov/pubmed/28132224 http://dx.doi.org/10.1186/1129-2377-16-S1-A164 |
| _version_ | 1782410427837186048 |
|---|---|
| author | Evangelista, Maurizio Piseddu, Francesco Maria |
| author_facet | Evangelista, Maurizio Piseddu, Francesco Maria |
| author_sort | Evangelista, Maurizio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4715154 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Springer Milan |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-47151542016-01-31 P052. Patient's subjective judgement on the ease of use, speed of onset of action, efficacy and tolerability of Diclofenac sodium HPβCD (25 mg/mL) solution for subcutaneous injection vs Diclofenac potassium 50 mg for oral solution for the acute treatment of migraine Evangelista, Maurizio Piseddu, Francesco Maria J Headache Pain Poster Presentation Springer Milan 2015-09-28 /pmc/articles/PMC4715154/ /pubmed/28132224 http://dx.doi.org/10.1186/1129-2377-16-S1-A164 Text en © Evangelista and Piseddu 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Evangelista, Maurizio Piseddu, Francesco Maria P052. Patient's subjective judgement on the ease of use, speed of onset of action, efficacy and tolerability of Diclofenac sodium HPβCD (25 mg/mL) solution for subcutaneous injection vs Diclofenac potassium 50 mg for oral solution for the acute treatment of migraine |
| title | P052. Patient's subjective judgement on the ease of use, speed of onset of action, efficacy and tolerability of Diclofenac sodium HPβCD (25 mg/mL) solution for subcutaneous injection vs Diclofenac potassium 50 mg for oral solution for the acute treatment of migraine |
| title_full | P052. Patient's subjective judgement on the ease of use, speed of onset of action, efficacy and tolerability of Diclofenac sodium HPβCD (25 mg/mL) solution for subcutaneous injection vs Diclofenac potassium 50 mg for oral solution for the acute treatment of migraine |
| title_fullStr | P052. Patient's subjective judgement on the ease of use, speed of onset of action, efficacy and tolerability of Diclofenac sodium HPβCD (25 mg/mL) solution for subcutaneous injection vs Diclofenac potassium 50 mg for oral solution for the acute treatment of migraine |
| title_full_unstemmed | P052. Patient's subjective judgement on the ease of use, speed of onset of action, efficacy and tolerability of Diclofenac sodium HPβCD (25 mg/mL) solution for subcutaneous injection vs Diclofenac potassium 50 mg for oral solution for the acute treatment of migraine |
| title_short | P052. Patient's subjective judgement on the ease of use, speed of onset of action, efficacy and tolerability of Diclofenac sodium HPβCD (25 mg/mL) solution for subcutaneous injection vs Diclofenac potassium 50 mg for oral solution for the acute treatment of migraine |
| title_sort | p052. patient's subjective judgement on the ease of use, speed of onset of action, efficacy and tolerability of diclofenac sodium hpβcd (25 mg/ml) solution for subcutaneous injection vs diclofenac potassium 50 mg for oral solution for the acute treatment of migraine |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715154/ https://www.ncbi.nlm.nih.gov/pubmed/28132224 http://dx.doi.org/10.1186/1129-2377-16-S1-A164 |
| work_keys_str_mv | AT evangelistamaurizio p052patientssubjectivejudgementontheeaseofusespeedofonsetofactionefficacyandtolerabilityofdiclofenacsodiumhpbcd25mgmlsolutionforsubcutaneousinjectionvsdiclofenacpotassium50mgfororalsolutionfortheacutetreatmentofmigraine AT piseddufrancescomaria p052patientssubjectivejudgementontheeaseofusespeedofonsetofactionefficacyandtolerabilityofdiclofenacsodiumhpbcd25mgmlsolutionforsubcutaneousinjectionvsdiclofenacpotassium50mgfororalsolutionfortheacutetreatmentofmigraine |